{"id":186710,"name":"GLENMARK PHARMACEUTICALS, INC., USA","slug":"glenmark-pharmaceuticals-inc-usa","state":"NJ","country":"United States of America","description":"Leading,integrated, research-driven, global pharmaceutical manufacturing company.","totalSpending":980000,"filings":20,"yearlySpending":[{"year":2018,"income":200000},{"year":2019,"income":250000},{"year":2020,"income":200000},{"year":2021,"income":200000},{"year":2022,"income":130000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"PHA","display":"Pharmacy"},{"code":"CPT","display":"Copyright/Patent/Trademark"}],"firms":["KOUNTOUPES DENHAM CARR & REID, LLC"],"lobbyists":["ROSE SULLIVAN (LISTED IN ERROR)","DAVID PELUSO","MARY REID","LISA KOUNTOUPES","MJ KENNY","ADAM HECHAVARRIA","JULIE CARR"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Executive Office of the President (EOP)"],"sampleDescriptions":["General education about the generic pharmaceutical industry.","Issues related to Medicaid CPI Penalty.","General information about the company and the industry.  Issues related to affordability and pricing of pharmaceuticals.","General education about the generic pharmaceutical industry.","Issues related to Medicaid CPI Penalty."]}